EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Label-Free Malignancy Phenotyping of Living Cancer Cells by High-Performance Surface-Enhanced Raman Spectroscopy Substrates

Jiwon Yun iD, Hyeim Yu, Youngho Yun, Wonil Nam

Micromachines · 09.04.2026 · 17 (4) · 461

DOI: 10.3390/mi17040461 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Micromachines, online erschienen am 09.04.2026. Verfasst von Jiwon Yun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intelligent Robotics Engineering, Pukyong National University, Busan 48513, Republic of Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pukyong National University, National Rsearch Foundation (NRF), National Research Foundation (NRF), Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Surface-enhanced Raman spectroscopy (SERS) amplifies Raman scattering by placing molecules in the near-field of plasmonic nanostructures, enabling label-free molecular fingerprinting. While attractive for living cell phenotyping, many cellular SERS works rely on internalized colloidal nanoparticles, leading to variable uptake/localization, aggregation-driven hotspot fluctuations, and potential cellular perturbation. Here, we report a chip-like Au/SiO2 nanolaminate SERS substrate that supports direct culture and label-free measurements of living cells on spatially defined hotspots without nanoparticle uptake. The periodic nanolaminate forms dense nanogaps and is engineered for 785 nm excitation, providing uniform enhancement over a large, culture-compatible area with high hotspot uniformity. By engineering the cell–substrate nano–bio interface, the platform enables reproducible acquisition of intrinsic cellular vibrational fingerprints under physiological conditions without Raman tags. Using MCF-7 and MDA-MB-231 breast cancer cells, we collected hundreds of spectra per line, and MDA-MB-231 exhibited broader spectral variations, indicating greater heterogeneity. Principal component analysis and linear discriminant analysis achieved 99% classification accuracy for MCF-7 and MDA-MB-231, and bright-field imaging confirmed preserved adhesion and canonical morphologies. This chip-based, label-free living cell SERS platform enables scalable, nonperturbative phenotyping and may support rapid malignancy classification and treatment response screening across subtle cancer states.

Schlagwörter

Stichwörter der Autor:innen

cancerlabel-freeliving cellsmultivariate analysissurface-enhanced Raman spectroscopy

Autor:innen und Institutionen

  • Department of Intelligent Robotics Engineering, Pukyong National University, Busan 48513, Republic of Korea.
  • Department of Statistics, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA.
  • Department of Electronic Engineering, Pukyong National University, Busan 48513, Republic of Korea.

ORCID-Profile: Jiwon Yun

Förderung

  • Pukyong National University
  • National Rsearch Foundation (NRF)
  • National Research Foundation (NRF), Republic of Korea

Zitieren

APA

Yun, J., Yu, H., Yun, Y., & Nam, W. (2026). Label-Free Malignancy Phenotyping of Living Cancer Cells by High-Performance Surface-Enhanced Raman Spectroscopy Substrates. Micromachines, 17(4), 461. https://doi.org/10.3390/mi17040461

Vancouver

Yun J, Yu H, Yun Y, Nam W. Label-Free Malignancy Phenotyping of Living Cancer Cells by High-Performance Surface-Enhanced Raman Spectroscopy Substrates. Micromachines. 2026;17(4):461. doi:10.3390/mi17040461

BibTeX
@article{Yun2026,
  author = {Yun, Jiwon and Yu, Hyeim and Yun, Youngho and Nam, Wonil},
  title = {Label-Free Malignancy Phenotyping of Living Cancer Cells by High-Performance Surface-Enhanced Raman Spectroscopy Substrates},
  journal = {Micromachines},
  year = {2026},
  volume = {17},
  number = {4},
  pages = {461},
  doi = {10.3390/mi17040461}
}
Kostenlos starten →